Review





Similar Products

90
Millipore heat shock proteins
Heat Shock Proteins, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/heat+shock+protein/nct00704626-3-9-12?v=Millipore
Average 90 stars, based on 1 article reviews
heat shock proteins - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

86
Proteostasis Therapeutics chaperones heat shock protein 70 hsp70
Chaperones Heat Shock Protein 70 Hsp70, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/heat+shock+protein/pmc13273482-122-28-42?v=Proteostasis+Therapeutics
Average 86 stars, based on 1 article reviews
chaperones heat shock protein 70 hsp70 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Proteostasis Therapeutics heat shock proteins hsps
Heat Shock Proteins Hsps, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/heat+shock+protein/pm42259777-117-35-18?v=Proteostasis+Therapeutics
Average 86 stars, based on 1 article reviews
heat shock proteins hsps - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Proteostasis Therapeutics heat shock protein 90 hsp90
Heat Shock Protein 90 Hsp90, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/heat+shock+protein/pm42167645-15-0-29?v=Proteostasis+Therapeutics
Average 86 stars, based on 1 article reviews
heat shock protein 90 hsp90 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Gehrmann Laboratories heat shock proteins
Heat Shock Proteins, supplied by Gehrmann Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/heat+shock+protein/pm42113470-512-17-2?v=Gehrmann+Laboratories
Average 86 stars, based on 1 article reviews
heat shock proteins - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

94
OriGene heat shock protein 70
Case 2: Pathology of S5 hepatocellular carcinoma: High magnification reveals tumor cells that are polygonal in shape, with round nuclei, prominent nucleoli and cytoplasm exhibiting a finely granular appearance. (A) H&E (magnification, ×100; scale bar, 73 µm). Immunohistochemical results: (B) Arginase-1 (+), with arrows indicating cytoplasmic positivity in tumor cells; (C) hepatocyte paraffin 1 (+), with arrows indicating cytoplasmic granular positivity; (D) Ki-67 (~15%+ in active area), with arrows indicating nuclear positivity in proliferating tumor cells; (E) glutamine synthetase (+), with arrows indicating cytoplasmic positivity in a map-like distribution pattern; (F) glypican-3 (focally +), with arrows indicating focal cytoplasmic and membranous positivity; (G) heat shock <t>protein</t> <t>70</t> (focally +), with arrows indicating focal nuclear and cytoplasmic positivity; and (H) CD34 (showing diffuse capillary distribution), with arrows highlighting the characteristic sinusoidal endothelial staining pattern (magnification, ×40; scale bar, 221 µm).
Heat Shock Protein 70, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/heat+shock+protein/pmc13051470-55-119-130?v=OriGene
Average 94 stars, based on 1 article reviews
heat shock protein 70 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

86
Proteostasis Therapeutics small heat shock proteins
Case 2: Pathology of S5 hepatocellular carcinoma: High magnification reveals tumor cells that are polygonal in shape, with round nuclei, prominent nucleoli and cytoplasm exhibiting a finely granular appearance. (A) H&E (magnification, ×100; scale bar, 73 µm). Immunohistochemical results: (B) Arginase-1 (+), with arrows indicating cytoplasmic positivity in tumor cells; (C) hepatocyte paraffin 1 (+), with arrows indicating cytoplasmic granular positivity; (D) Ki-67 (~15%+ in active area), with arrows indicating nuclear positivity in proliferating tumor cells; (E) glutamine synthetase (+), with arrows indicating cytoplasmic positivity in a map-like distribution pattern; (F) glypican-3 (focally +), with arrows indicating focal cytoplasmic and membranous positivity; (G) heat shock <t>protein</t> <t>70</t> (focally +), with arrows indicating focal nuclear and cytoplasmic positivity; and (H) CD34 (showing diffuse capillary distribution), with arrows highlighting the characteristic sinusoidal endothelial staining pattern (magnification, ×40; scale bar, 221 µm).
Small Heat Shock Proteins, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/heat+shock+protein/pm42049738-389-4-10?v=Proteostasis+Therapeutics
Average 86 stars, based on 1 article reviews
small heat shock proteins - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Keming Electronics Development Co Ltd heat shock protein hsp17 2 b
Case 2: Pathology of S5 hepatocellular carcinoma: High magnification reveals tumor cells that are polygonal in shape, with round nuclei, prominent nucleoli and cytoplasm exhibiting a finely granular appearance. (A) H&E (magnification, ×100; scale bar, 73 µm). Immunohistochemical results: (B) Arginase-1 (+), with arrows indicating cytoplasmic positivity in tumor cells; (C) hepatocyte paraffin 1 (+), with arrows indicating cytoplasmic granular positivity; (D) Ki-67 (~15%+ in active area), with arrows indicating nuclear positivity in proliferating tumor cells; (E) glutamine synthetase (+), with arrows indicating cytoplasmic positivity in a map-like distribution pattern; (F) glypican-3 (focally +), with arrows indicating focal cytoplasmic and membranous positivity; (G) heat shock <t>protein</t> <t>70</t> (focally +), with arrows indicating focal nuclear and cytoplasmic positivity; and (H) CD34 (showing diffuse capillary distribution), with arrows highlighting the characteristic sinusoidal endothelial staining pattern (magnification, ×40; scale bar, 221 µm).
Heat Shock Protein Hsp17 2 B, supplied by Keming Electronics Development Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/heat+shock+protein/pm41875799-8-2-24?v=Keming+Electronics+Development+Co+Ltd
Average 86 stars, based on 1 article reviews
heat shock protein hsp17 2 b - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

93
Tocris quercetin small heat shock protein phosphorylation inhibitor cat no 1125 2 3 4 dihydroxyphenyl 3 5 7 trihydrox y 4h
Case 2: Pathology of S5 hepatocellular carcinoma: High magnification reveals tumor cells that are polygonal in shape, with round nuclei, prominent nucleoli and cytoplasm exhibiting a finely granular appearance. (A) H&E (magnification, ×100; scale bar, 73 µm). Immunohistochemical results: (B) Arginase-1 (+), with arrows indicating cytoplasmic positivity in tumor cells; (C) hepatocyte paraffin 1 (+), with arrows indicating cytoplasmic granular positivity; (D) Ki-67 (~15%+ in active area), with arrows indicating nuclear positivity in proliferating tumor cells; (E) glutamine synthetase (+), with arrows indicating cytoplasmic positivity in a map-like distribution pattern; (F) glypican-3 (focally +), with arrows indicating focal cytoplasmic and membranous positivity; (G) heat shock <t>protein</t> <t>70</t> (focally +), with arrows indicating focal nuclear and cytoplasmic positivity; and (H) CD34 (showing diffuse capillary distribution), with arrows highlighting the characteristic sinusoidal endothelial staining pattern (magnification, ×40; scale bar, 221 µm).
Quercetin Small Heat Shock Protein Phosphorylation Inhibitor Cat No 1125 2 3 4 Dihydroxyphenyl 3 5 7 Trihydrox Y 4h, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/heat+shock+protein/10__1096_slash_fj__202504690r-54-270-292?v=Tocris
Average 93 stars, based on 1 article reviews
quercetin small heat shock protein phosphorylation inhibitor cat no 1125 2 3 4 dihydroxyphenyl 3 5 7 trihydrox y 4h - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

Image Search Results


Case 2: Pathology of S5 hepatocellular carcinoma: High magnification reveals tumor cells that are polygonal in shape, with round nuclei, prominent nucleoli and cytoplasm exhibiting a finely granular appearance. (A) H&E (magnification, ×100; scale bar, 73 µm). Immunohistochemical results: (B) Arginase-1 (+), with arrows indicating cytoplasmic positivity in tumor cells; (C) hepatocyte paraffin 1 (+), with arrows indicating cytoplasmic granular positivity; (D) Ki-67 (~15%+ in active area), with arrows indicating nuclear positivity in proliferating tumor cells; (E) glutamine synthetase (+), with arrows indicating cytoplasmic positivity in a map-like distribution pattern; (F) glypican-3 (focally +), with arrows indicating focal cytoplasmic and membranous positivity; (G) heat shock protein 70 (focally +), with arrows indicating focal nuclear and cytoplasmic positivity; and (H) CD34 (showing diffuse capillary distribution), with arrows highlighting the characteristic sinusoidal endothelial staining pattern (magnification, ×40; scale bar, 221 µm).

Journal: Oncology Letters

Article Title: Comprehensive treatment for two patients with small cell neuroendocrine carcinoma of the liver: A case report and literature review

doi: 10.3892/ol.2026.15544

Figure Lengend Snippet: Case 2: Pathology of S5 hepatocellular carcinoma: High magnification reveals tumor cells that are polygonal in shape, with round nuclei, prominent nucleoli and cytoplasm exhibiting a finely granular appearance. (A) H&E (magnification, ×100; scale bar, 73 µm). Immunohistochemical results: (B) Arginase-1 (+), with arrows indicating cytoplasmic positivity in tumor cells; (C) hepatocyte paraffin 1 (+), with arrows indicating cytoplasmic granular positivity; (D) Ki-67 (~15%+ in active area), with arrows indicating nuclear positivity in proliferating tumor cells; (E) glutamine synthetase (+), with arrows indicating cytoplasmic positivity in a map-like distribution pattern; (F) glypican-3 (focally +), with arrows indicating focal cytoplasmic and membranous positivity; (G) heat shock protein 70 (focally +), with arrows indicating focal nuclear and cytoplasmic positivity; and (H) CD34 (showing diffuse capillary distribution), with arrows highlighting the characteristic sinusoidal endothelial staining pattern (magnification, ×40; scale bar, 221 µm).

Article Snippet: The following primary antibodies were used: Pan-cytokeratin (CKpan; cat. no. ZM-0069), vimentin (cat. no. ZM-0260), CgA (cat. no. ZA-0507), Syn (cat. no. ZA-0569), cluster of differentiation 56 (CD56; cat. no. ZM-0427), TTF-1 (cat. no. ZM-0270), arginase-1 (cat. no. ZA-0641), HepPar-1 (cat. no. ZM-0133), P53 (cat. no. ZM-0408), Ki-67 (cat. no. ZM-0166), CD34 (cat. no. ZM-0046), CK19 (cat. no. ZM-0074), alpha-fetoprotein (AFP; cat. no. ZM-0008), CK7 (cat. no. ZM-0071), CK20 (cat. no. ZM-0072), Villin (cat. no. ZM-0441), caudal type homeobox 2 (CDX2; cat. no. ZA-0520), MutL homolog 1 (MLH1; cat. no. ZA-0544), MutS homolog 2 (MSH2; cat. no. ZA-0542), MSH6 (cat. no. ZA-0546), postmeiotic segregation increased 2 (PMS2; cat. no. ZA-0548), glutamine synthetase (cat. no. ZA-0645), glypican-3 (cat. no. ZM-0446), heat shock protein 70 (HSP70; cat. no. ZA-0580; all ready-to-use; from OriGene Technologies, Inc.), and programmed cell death ligand 1 (PD-L1; cat. no. M3653; dilution 1:50; Dako; Agilent Technologies, Inc.).

Techniques: Immunohistochemical staining, Staining